Sequential Compression Device and Range of Motion Exercises on Distributive Peripheral Edema and Hemodynamic Stability Among Patients in Critical Care Units

NCT ID: NCT07305870

Last Updated: 2025-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

118 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-28

Study Completion Date

2026-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives of The Study:

1. Assess the effectiveness of sequential compression device on distributive peripheral edema and hemodynamic stability for patients in critical care units.
2. Assess the effectiveness of range of motion on distributive peripheral edema and hemodynamic stability for patients in critical care units.
3. Evaluate the synergic effectiveness of sequential compression device and range of motion on distributive peripheral edema and hemodynamic stability for patients in critical care units
4. Find out the differences between the effectiveness of sequential compression device, range of motion, and synergic effectiveness of both interventions on distributive peripheral edema and hemodynamic stability
5. Find out relationships between the effectiveness of sequential compression device, range of motion, and synergic effectiveness of both interventions with patients' demographic characteristics.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Globally, approximately (13-20) million people treated in intensive care units (ICUs) each year, where common complications such as edema are due to prolonged immobility and critical illness (Ramadan et al., 2025). Edema refers to accumulation of excess fluid in body tissues, manifesting in multi forms such as cerebral, pulmonary, or ocular edema. Peripheral edema considered one of the most prevalent types, specifically represents to swelling in the limbs (Besharat et al., 2021). It caused by imbalance between oncotic and hydrostatic pressures, leading to increased capillary permeability and fluid accumulation in the interstitial space(Smith et al., 2024).

Danziger et al., (2016)found that hospital mortality was significantly higher in those presenting with peripheral edema (22.2%) compared with those without (12.6%) among 12,778 critically ill patients. Also, the severity of edema at admission correlated with increased mortality risk.

The prevalence of peripheral lower limb edema among older adults in U.S was 20.0%, 19.4%, 19.0%, 19.0%, and 19.1% in 2000, 2004, 2008, 2012, and 2016, respectively. It was significantly associated with clinical, demographic, and lifestyle factors, including obesity, diabetes, hypertension, pain, low physical activity, mobility limitations, advanced age, female sex, minority race, and low socioeconomic status (Besharat et al., 2021).

In Japan, the Ministry of Health, Labor, and Welfare reported an increase in the number of patients with severe motion disabilities, particularly among individuals over 60 years old (Suehiro et al., 2014). Similarly, data from the Health and Retirement Study revealed that chronic peripheral edema affects approximately 19% to 20% of older adults, particularly among women, racial minorities, and individuals with limited mobility (Besharat et al., 2021).

Peripheral edema is a multifactorial and complex condition that affects patients suffering from a various of diseases. Its underlying pathology varies considerably, with common causes including congestive heart failure (CHF), liver disease, vascular conditions such as chronic venous insufficiency, and postoperative surgical complications (Smith et al., 2024).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Edema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Sequential Compression Device (SCD) protocol involves a pump linked to calf and thigh braces with individual tubes, applying moderate pressure of approximately 60mmHg through a graduated air chamber in a sequential cycle across four compartments. The inflation lasts for 12 seconds followed by a 48-second deflation, with sessions lasting 2 hours daily for 5 consecutive days.

The Range of Motion (ROM) Exercises program entails 20 minutes of flexion-extension movements for both limbs, conducted in two sessions per day over 5 days. Patients perform passive range of motion exercises for upper extremities including movements of fingers, wrists, elbows, and shoulders, as well as for lower extremities encompassing toe, ankle, knee, and hip movements.

In addition control group will receive slandered care which is limps elevation
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

non

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sequential Compression Device group

Sequential Compression Device (SCD) participants group involves a pump linked to calf and thigh braces with individual tubes, applying moderate pressure of approximately 60mmHg through a graduated air chamber in a sequential cycle across four compartments. The inflation lasts for 12 seconds followed by a 48-second deflation, with sessions lasting 2 hours daily for 5 consecutive days.

Group Type ACTIVE_COMPARATOR

Sequential compression device

Intervention Type DEVICE

Sequential Compression Device (SCD) protocol involves a pump linked to calf and thigh braces with individual tubes, applying moderate pressure of approximately 60mmHg through a graduated air chamber in a sequential cycle across four compartments. The inflation lasts for 12 seconds followed by a 48-second deflation, with sessions lasting 2 hours daily for 5 consecutive days.

Range of Motion exercises

The Range of Motion (ROM) Exercises program entails 20 minutes of flexion-extension movements for both limbs, conducted in two sessions per day over 5 days. Patients perform passive range of motion exercises for upper extremities including movements of fingers, wrists, elbows, and shoulders, as well as for lower extremities encompassing toe, ankle, knee, and hip movements. In addition control group will receive slandered care which is limps elevation

Group Type ACTIVE_COMPARATOR

legs exercises

Intervention Type DEVICE

The Range of Motion (ROM) Exercises program entails 20 minutes of flexion-extension movements for both limbs, conducted in two sessions per day over 5 days. Patients perform passive range of motion exercises for upper extremities including movements of fingers, wrists, elbows, and shoulders, as well as for lower extremities encompassing toe, ankle, knee, and hip movements. In addition control group will receive slandered care which is limps elevation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sequential compression device

Sequential Compression Device (SCD) protocol involves a pump linked to calf and thigh braces with individual tubes, applying moderate pressure of approximately 60mmHg through a graduated air chamber in a sequential cycle across four compartments. The inflation lasts for 12 seconds followed by a 48-second deflation, with sessions lasting 2 hours daily for 5 consecutive days.

Intervention Type DEVICE

legs exercises

The Range of Motion (ROM) Exercises program entails 20 minutes of flexion-extension movements for both limbs, conducted in two sessions per day over 5 days. Patients perform passive range of motion exercises for upper extremities including movements of fingers, wrists, elbows, and shoulders, as well as for lower extremities encompassing toe, ankle, knee, and hip movements. In addition control group will receive slandered care which is limps elevation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients who were hospitalized in critical care units.
* Subjects over the age of 18 years.
* Presence of peripheral edema (pitting edema ≥1+ in lower extremities).
* Patients how are hemodynamically stable.
* Patients how are able to tolerate positioning for interventions.

Exclusion Criteria

* Patients with lymphedema.
* Patients with chronic kidney disease.
* patients with presence of deep vein thrombosis, severe peripheral arterial disease, or phlebitis.
* patients with open wounds, ulcers, or skin infections on lower limbs.
* patients with fractures, orthopedic surgery, or joint immobility in lower extremities.
* patients with severe cardiac failure or pulmonary edema.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Karbala University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hussein Hamza Jawad

Masters graduate student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hussein H Jawad MGS study principal investigator

Role: PRINCIPAL_INVESTIGATOR

Kerbala health department

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kerbala health department

Karbala, Center, Iraq

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iraq

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hussein H Jawad MGS

Role: CONTACT

Phone: +9647815563674

Email: [email protected]

Hassan A Athbi Assoc.Prof, Assoc.Prof

Role: CONTACT

Phone: +9647721902514

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

uok.coN.25.099

Identifier Type: -

Identifier Source: org_study_id